(Q24194816)

6

Albert Wiegman

0 references

Alpo Vuorio

1

Alpo Vuorio

0 references

Petri T Kovanen

3

Petri T Kovanen

0 references

Jaana Kuoppala

2

Jaana Kuoppala

0 references

Serena Tonstad

5

Serena Tonstad

0 references

Euridiki Drogari

7

Cochrane Database of Systematic Reviews

Euridiki Drogari

0 references

publication date

23 July 2014

0 references

published in

0 references

cites work

Efficacy and safety of lovastatin therapy in adolescent girls with heterozygous familial hypercholesterolemia

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006401.PUB3

Association of specific LDL receptor gene mutations with differential plasma lipoprotein response to simvastatin in young French Canadians with heterozygous familial hypercholesterolemia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006401.PUB3

Early statin therapy restores endothelial function in children with familial hypercholesterolemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006401.PUB3

Efficacy and safety of statin therapy in children with familial hypercholesterolemia: a randomized, double-blind, placebo-controlled trial with simvastatin

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006401.PUB3

Short-term efficacy and safety of pravastatin in 72 children with familial hypercholesterolemia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006401.PUB3

Efficacy and safety of atorvastatin in children and adolescents with familial hypercholesterolemia or severe hyperlipidemia: a multicenter, randomized, placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006401.PUB3

Efficacy and safety of statin therapy in children with familial hypercholesterolemia: a randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006401.PUB3

Long-term treatment with atorvastatin in adolescent males with heterozygous familial hypercholesterolemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006401.PUB3

Long-term follow-up of statin treatment in a cohort of children with familial hypercholesterolemia: efficacy and tolerability

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006401.PUB3

An eight-week trial investigating the efficacy and tolerability of atorvastatin for children and adolescents with heterozygous familial hypercholesterolemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006401.PUB3

Pharmacokinetics and pharmacodynamics of pravastatin in children with familial hypercholesterolemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006401.PUB3

Efficacy and safety of pravastatin in children and adolescents with heterozygous familial hypercholesterolemia: a prospective clinical follow-up study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006401.PUB3

A randomized crossover trial of combination pharmacologic therapy in children with familial hyperlipidemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006401.PUB3

Statin therapy in a kindred with both apolipoprotein B and low density lipoprotein receptor gene defects.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006401.PUB3

Professional athletes suffering from familial hypercholesterolaemia rarely tolerate statin treatment because of muscular problems

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006401.PUB3

Statin treatment for children and adolescents with heterozygous familial hypercholesterolaemia: a systematic review and meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006401.PUB3

A systematic review and meta-analysis of statin therapy in children with familial hypercholesterolemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006401.PUB3

Association of HMG-CoA reductase inhibitors with neuropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006401.PUB3

Statin safety: an overview and assessment of the data--2005.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006401.PUB3

Adverse effects of statins - mechanisms and consequences

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006401.PUB3

An assessment of statin safety by neurologists.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006401.PUB3

Risk of incident diabetes among patients treated with statins: population based study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006401.PUB3

Cholesterol and cataracts

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006401.PUB3

Patients with elevated liver enzymes are not at higher risk for statin hepatotoxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006401.PUB3

Statin-associated peripheral neuropathy: review of the literature

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006401.PUB3

Lipid screening and cardiovascular health in childhood

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006401.PUB3

Statins and liver toxicity: a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006401.PUB3

Management of familial hypercholesterolemia in children and young adults: consensus paper developed by a panel of lipidologists, cardiologists, paediatricians, nutritionists, gastroenterologists, general practitioners and a patient organization.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006401.PUB3

Recent statin use and cataract surgery

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006401.PUB3

Analysis of the frequency and spectrum of mutations recognised to cause familial hypercholesterolaemia in routine clinical practice in a UK specialist hospital lipid clinic

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006401.PUB3

Familial hypercholesterolemia: screening, diagnosis and management of pediatric and adult patients: clinical guidance from the National Lipid Association Expert Panel on Familial Hypercholesterolemia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006401.PUB3

Regulation of the mevalonate pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006401.PUB3

Genetic screening protocol for familial hypercholesterolemia which includes splicing defects gives an improved mutation detection rate

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006401.PUB3

Absence of effect of simvastatin on the progression of lens opacities in a randomised placebo controlled study. Oxford Cholesterol Study Group.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006401.PUB3

The type of mutation in the low density lipoprotein receptor gene influences the cholesterol-lowering response of the HMG-CoA reductase inhibitor simvastatin in patients with heterozygous familial hypercholesterolaemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006401.PUB3

Measuring inconsistency in meta-analyses

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006401.PUB3

Unintended effects of statins in men and women in England and Wales: population based cohort study using the QResearch database

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006401.PUB3

Relation of peripheral flow-mediated vasodilatation and coronary arterial calcium in young patients with heterozygous familial hypercholesterolemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006401.PUB3

Mutational analysis in UK patients with a clinical diagnosis of familial hypercholesterolaemia: relationship with plasma lipid traits, heart disease risk and utility in relative tracing

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006401.PUB3

Genetic causes of familial hypercholesterolaemia in patients in the UK: relation to plasma lipid levels and coronary heart disease risk

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006401.PUB3

Narrative review: statin-related myopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006401.PUB3

Systematic reviews in health care: Assessing the quality of controlled clinical trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006401.PUB3

Drug treatment of lipid disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006401.PUB3

Low-density lipoprotein receptor genotype and response to pravastatin in children with familial hypercholesterolemia: substudy of an intima-media thickness trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006401.PUB3

Familial hypercholesterolemia (one form of familial type II hyperlipoproteinemia). A study of its biochemical, genetic and clinical presentation in childhood

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006401.PUB3

Statin safety: a systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006401.PUB3

Screening for familial hyper-beta-lipoproteinaemia in children in hospital

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006401.PUB3

Development of coronary heart disease in familial hypercholesterolemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006401.PUB3

Familial hypercholesterolemia in children and adolescents

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006401.PUB3

Final conclusions and recommendations of the National Lipid Association Statin Safety Assessment Task Force.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006401.PUB3

Genetic and environmental factors affecting the response to statin therapy in patients with molecularly defined familial hypercholesterolaemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006401.PUB3

Familial defective apolipoprotein B-100: a review, including some comparisons with familial hypercholesterolaemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006401.PUB3

Familial hypercholesterolaemia is underdiagnosed and undertreated in the general population: guidance for clinicians to prevent coronary heart disease: consensus statement of the European Atherosclerosis Society

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006401.PUB3

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006401.PUB3

Dietary treatment for familial hypercholesterolaemia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006401.PUB3

Cerivastatin and reports of fatal rhabdomyolysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006401.PUB3

Use of low-density lipoprotein cholesterol gene score to distinguish patients with polygenic and monogenic familial hypercholesterolaemia: a case-control study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006401.PUB3

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006401.PUB3

Low-density lipoprotein receptor gene mutations and cardiovascular risk in a large genetic cascade screening population

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006401.PUB3

Low-density lipoprotein receptor gene familial hypercholesterolemia variant database: update and pathological assessment

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006401.PUB3

Endothelial dysfunction, but not structural atherosclerosis, is evident early in children with heterozygous familial hypercholesterolemia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006401.PUB3

Influence of LDL receptor gene mutation and apo E polymorphism on lipoprotein response to simvastatin treatment among adolescents with heterozygous familial hypercholesterolemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006401.PUB3

Familial hypercholesterolaemia in Finland: common, rare and mild mutations of the LDL receptor and their clinical consequences. Finnish FH-group

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006401.PUB3

Statin treatment of children with familial hypercholesterolemia--trying to balance incomplete evidence of long-term safety and clinical accountability: are we approaching a consensus?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006401.PUB3

Statins for children with familial hypercholesterolemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006401.PUB3

Drug Therapy of High-Risk Lipid Abnormalities in Children and Adolescents

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006401.PUB3

Safety and tolerability of cholesterol lowering with simvastatin during 5 years in the Scandinavian Simvastatin Survival Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006401.PUB3

7 January 2021

Efficacy and safety of lovastatin in adolescent males with heterozygous familial hypercholesterolemia: a randomized controlled trial

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006401.PUB3

7 January 2021

Association of statin use with cataracts: a propensity score-matched analysis

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006401.PUB3

7 January 2021

The effect of low-dose simvastatin in children with familial hypercholesterolaemia: a 1-year observation

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006401.PUB3

7 January 2021

Lack of effect of probucol on atheroma formation in cholesterol-fed rabbits kept at comparable plasma cholesterol levels

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006401.PUB3

7 January 2021

Persistence with statins and incident cataract: a population-based historical cohort study

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006401.PUB3

7 January 2021

INTERIM guidelines for the diagnosis and management of familial hypercholesterolaemia

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006401.PUB3

7 January 2021

Influence of genotype at the low density lipoprotein (LDL) receptor gene locus on the clinical phenotype and response to lipid-lowering drug therapy in heterozygous familial hypercholesterolaemia. The Familial Hypercholesterolaemia Regression Study

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006401.PUB3

7 January 2021

Efficacy and safety of fluvastatin in children and adolescents with heterozygous familial hypercholesterolaemia

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006401.PUB3

7 January 2021

Phenotypic variation among familial hypercholesterolemics heterozygous for either one of two Afrikaner founder LDL receptor mutations

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006401.PUB3

7 January 2021

ACC/AHA/NHLBI Clinical Advisory on the Use and Safety of Statins

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006401.PUB3

7 January 2021

Molecular basis of autosomal dominant hypercholesterolemia: assessment in a large cohort of hypercholesterolemic children

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006401.PUB3

7 January 2021